This infographic provides a visual, at-a-glance overview of why biomarkers in schizophrenia are relevant for clinicians, what is necessary to bring biomarkers to the clinic and neuroimaging biomarkers in schizophrenia management.
Related content
In this video, Professor Dr. Ana Catalan explores whether psychotic disorders can be prevented and reviews the latest evidence on early intervention in psychosis. She explains how personalized, evidence-based care can enhance quality of life, daily functioning, and long-term recovery for people at risk of or experiencing psychosis.
Schizophrenia is associated with substantial disability, reduced life expectancy, and increased rates of psychiatric and physical comorbidities.
This slide deck reviews schizophrenia trajectories from high-risk states to long-term outcomes, highlighting prognostic factors, relapse, recovery, treatment adherence, and functional outcomes.